Drug Discovery Informatics Market Size, Share, and Growth Forecast to 2031
Drug Discovery Informatics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow (Discovery Informatics and Drug Development), Service (Sequence Analysis Platform, Molecular Modeling, Clinical Trial Data Management, Docking, and Others), Solution (Software and Services), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
- Status : Published
- Report Code : TIPHE100000965
- Category : Life Sciences
- No. of Pages : 200
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Workflow, Service, Solution, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
In 2024, the global drug discovery informatics market was valued at approximately US$ 3.39 billion. It is projected to reach US$ 8.17 billion by 2031, registering a CAGR of 13.7% during 2025–2031.
As of 2025:North America leads the market with a share of nearly 45.3%, which is mainly attributable to extraordinary R&D investments and technological innovation.The continent of Europe has a 20.47% market share; the area is supported by the governments with extensive policies and a mutually beneficial research ecosystem.The Asia Pacific region is the most dynamic area with a forecasted CAGR of 14.2% from 2025 to 2031, resulting from substantial government investments and the growing pharmaceutical capabilities.
Challenges include:1. High Implementation and Licensing Costs: The high cost associated with the implementation, licensing, and maintenance is one of the essential restraints that limit the extensive use of drug discovery informatics solutions.2. Shortage of Skilled Professionals: The lack of skilled professionals who have a profound knowledge of both life sciences and data analytics constitutes a critical restraint to the drug discovery informatics market’s growth.3. Data Privacy and Security Concerns: With the advent of big data and digital transformation, data privacy and security have become intimidating factors that hinder the growth of the drug discovery informatics market.
The market is primarily driven by:1. Rise in Prevalence of Chronic Diseases:2. The increasing prevalence of chronic diseases across the globe is one of the main reasons for the expansion of the drug discovery informatics market.3. Advancements in Personalized Medicine:4. The developments in personalized medicine have been the main factors in the transformation of the drug discovery informatics market.5. Surge in Government and Institutional Funding:6. Such large amounts of public money investments in the drug discovery informatics market are the main drivers of the market.
The discovery informatics segment is rapidly gaining traction in the drug discovery informatics market, serving as a key driver of innovation through data-driven strategies that enhance drug formulation and delivery.
Key industries utilizing drug discovery informatics include:1. Pharmaceutical and Biotechnology Companies: Pharmaceutical and biotechnology companies represent the largest end-user segment in the drug discovery informatics market, accounting for a substantial share of global demand.2. Contract Research Organizations (CROs): Contract research organizations (CROs) form a rapidly growing end-user segment in the drug discovery informatics market, playing a pivotal role in outsourced research and development for pharmaceutical and biotech companies.3. Others: Others include academic and research institutions, government agencies, and nonprofit organizations. These entities play a crucial role in early-stage drug research, basic science exploration, and public health-driven drug discovery initiatives.
AI and ML are revolutionizing drug discovery informatics by:1. Unprecedented Data Processing Capabilities: These technologies enable unprecedented data processing capabilities, allowing researchers to analyze complex biological, chemical, and clinical datasets at scale.2. Shorter Discovery Timelines: This leads to more effective drug candidates and personalized treatment options aligned with patient-specific biological profiles.
Major players include Certara; Infosys Ltd.; Collaborative Drug Discovery, Inc.; Jubliant Biosys; Curia Global, Inc.; and Chemaxon Ltd.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Drug Discovery Informatics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Platform Providers & Technology Innovators:
4.3.2 Pharmaceutical & Biotechnology Companies:
4.3.3 Regulatory Agencies & Public-Private Partnerships:
4.3.4 List of Vendors in Value Chain
5. Drug Discovery Informatics Market – Key Market Dynamics
5.1 Drug Discovery Informatics Market – Key Market Dynamics
5.2 Drivers
5.2.1 Rise in Prevalence of Chronic Diseases
5.2.2 Advancements in Personalized Medicine
5.2.3 Surge in Government and Institutional Funding
5.3 Restraints
5.3.1 High Implementation and Licensing Costs
5.3.2 Shortage of Skilled Professionals
5.3.3 Data Privacy and Security Concerns
5.4 Opportunities
5.4.1 Increase in Adoption of Cloud-Based Solutions
5.4.2 Advancements in Genomics and Biotechnology
5.4.3 Rise in Demand for Biologics
5.5 Trends
5.5.1 Integration of Artificial Intelligence and Machine Learning
5.5.2 Adoption of Real-World Evidence (RWE) and Real-World Data (RWD)
5.5.3 Utilization of Automation and Robotics
5.6 Impact of Drivers and Restraints:
6. Drug Discovery Informatics Market – Global Market Analysis
6.1 Drug Discovery Informatics Market Revenue (US$ Million), 2021–2031
6.2 Drug Discovery Informatics Market Forecast Analysis
7. Drug Discovery Informatics Market Analysis – by Workflow
7.1 Discovery Informatics
7.1.1 Overview
7.1.2 Discovery Informatics: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Drug Development
7.2.1 Overview
7.2.2 Drug Development: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
8. Drug Discovery Informatics Market Analysis – by Service
8.1 Sequence Analysis Platform
8.1.1 Overview
8.1.2 Sequence Analysis Platform: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Molecular Modelling
8.2.1 Overview
8.2.2 Molecular Modelling: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Trial Data Management
8.3.1 Overview
8.3.2 Clinical Trial Data Management: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Docking
8.4.1 Overview
8.4.2 Docking: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
9. Drug Discovery Informatics Market Analysis – by Solutions
9.1 Software
9.1.1 Overview
9.1.2 Software: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Services
9.2.1 Overview
9.2.2 Services: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
10. Drug Discovery Informatics Market Analysis – by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
10.2.1 Overview
10.2.2 Contract Research Organizations (CROs): Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
11. Drug Discovery Informatics Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Drug Discovery Informatics Market Overview
11.2.2 North America: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
11.2.3 North America: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.3.1 North America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Workflow
11.2.4 North America: Drug Discovery Informatics Market Breakdown, by Service
11.2.4.1 North America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Service
11.2.5 North America: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.5.1 North America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Solutions
11.2.6 North America: Drug Discovery Informatics Market Breakdown, by End User
11.2.6.1 North America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by End User
11.2.7 North America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.2.7.1 North America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.2.7.2 United States: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.2.1 United States: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.7.2.2 United States: Drug Discovery Informatics Market Breakdown, by Service
11.2.7.2.3 United States: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.7.2.4 United States: Drug Discovery Informatics Market Breakdown, by End User
11.2.7.3 Canada: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.3.1 Canada: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.7.3.2 Canada: Drug Discovery Informatics Market Breakdown, by Service
11.2.7.3.3 Canada: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.7.3.4 Canada: Drug Discovery Informatics Market Breakdown, by End User
11.2.7.4 Mexico: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.4.1 Mexico: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.7.4.2 Mexico: Drug Discovery Informatics Market Breakdown, by Service
11.2.7.4.3 Mexico: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.7.4.4 Mexico: Drug Discovery Informatics Market Breakdown, by End User
11.3 Europe
11.3.1 Europe Drug Discovery Informatics Market Overview
11.3.2 Europe: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
11.3.3 Europe: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.3.1 Europe: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Workflow
11.3.4 Europe: Drug Discovery Informatics Market Breakdown, by Service
11.3.4.1 Europe: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Service
11.3.5 Europe: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.5.1 Europe: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Solutions
11.3.6 Europe: Drug Discovery Informatics Market Breakdown, by End User
11.3.6.1 Europe: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by End User
11.3.7 Europe: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.3.7.1 Europe: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.3.7.2 Germany: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.2.1 Germany: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.2.2 Germany: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.2.3 Germany: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.2.4 Germany: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.3 United Kingdom: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.3.1 United Kingdom: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.3.2 United Kingdom: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.3.3 United Kingdom: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.3.4 United Kingdom: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.4 France: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.4.1 France: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.4.2 France: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.4.3 France: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.4.4 France: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.5 Italy: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.5.1 Italy: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.5.2 Italy: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.5.3 Italy: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.5.4 Italy: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.6 Russia: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.6.1 Russia: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.6.2 Russia: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.6.3 Russia: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.6.4 Russia: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.7 Rest of Europe: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.7.2 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.7.3 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.7.4 Rest of Europe: Drug Discovery Informatics Market Breakdown, by End User
11.4 Asia Pacific
11.4.1 Asia Pacific Drug Discovery Informatics Market Overview
11.4.2 Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
11.4.3 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.3.1 Asia Pacific: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Workflow
11.4.4 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Service
11.4.4.1 Asia Pacific: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Service
11.4.5 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.5.1 Asia Pacific: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Solutions
11.4.6 Asia Pacific: Drug Discovery Informatics Market Breakdown, by End User
11.4.6.1 Asia Pacific: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by End User
11.4.7 Asia Pacific: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.4.7.1 Asia Pacific: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.4.7.2 China: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.2.1 China: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.2.2 China: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.2.3 China: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.2.4 China: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.3 Japan: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.3.1 Japan: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.3.2 Japan: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.3.3 Japan: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.3.4 Japan: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.4 India: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.4.1 India: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.4.2 India: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.4.3 India: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.4.4 India: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.5 Australia: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.5.1 Australia: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.5.2 Australia: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.5.3 Australia: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.5.4 Australia: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.6 South Korea: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.6.1 South Korea: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.6.2 South Korea: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.6.3 South Korea: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.6.4 South Korea: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.7 Rest of APAC: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.7.2 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.7.3 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.7.4 Rest of APAC: Drug Discovery Informatics Market Breakdown, by End User
11.5 Middle East and Africa
11.5.1 Middle East and Africa Drug Discovery Informatics Market Overview
11.5.2 Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
11.5.3 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.3.1 Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Workflow
11.5.4 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service
11.5.4.1 Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Service
11.5.5 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.5.1 Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Solutions
11.5.6 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by End User
11.5.7 Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.5.7.1 Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.5.7.2 Arabia: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.2.1 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.2.2 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.2.3 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.2.4 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by End User
11.5.7.3 South Africa: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.3.1 South Africa: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.3.2 South Africa: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.3.3 South Africa: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.3.4 South Africa: Drug Discovery Informatics Market Breakdown, by End User
11.5.7.4 United Arab Emirates: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.4.2 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.4.3 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.4.4 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by End User
11.5.7.5 Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.5.2 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.5.3 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.5.4 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User
11.6 South and Central America
11.6.1 South and Central America Drug Discovery Informatics Market Overview
11.6.2 South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
11.6.3 South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.3.1 South and Central America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Workflow
11.6.4 South and Central America: Drug Discovery Informatics Market Breakdown, by Service
11.6.4.1 South and Central America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Service
11.6.5 South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.5.1 South and Central America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Solutions
11.6.6 South and Central America: Drug Discovery Informatics Market Breakdown, by End User
11.6.6.1 South and Central America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by End User
11.6.7 South and Central America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.6.7.1 South and Central America: Drug Discovery Informatics Market – Revenue and Forecast Analysis – by Country
11.6.7.2 Brazil: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.2.1 Brazil: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.7.2.2 Brazil: Drug Discovery Informatics Market Breakdown, by Service
11.6.7.2.3 Brazil: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.7.2.4 Brazil: Drug Discovery Informatics Market Breakdown, by End User
11.6.7.3 Argentina: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.3.1 Argentina: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.7.3.2 Argentina: Drug Discovery Informatics Market Breakdown, by Service
11.6.7.3.3 Argentina: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.7.3.4 Argentina: Drug Discovery Informatics Market Breakdown, by End User
11.6.7.4 Rest of South and Central America: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.7.4.2 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Service
11.6.7.4.3 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.7.4.4 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Product Development
13.4 Mergers & Acquisitions
13.5 Partnership and Collaboration
13.6 Expansion
14. Company Profiles
14.1 Jubilant Pharma Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Certera
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dassault Systemes SE
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Revvity Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Selvita
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Eurofins Scientific SE
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Collaborative Drug Discovery, Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Charles River Laboratories InternationalInc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Illumina, Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 List of Abbreviations
List of Tables
Table 1. Drug Discovery Informatics Market Segmentation
Table 2. Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million)
Table 3. Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 4. Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 5. Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 6. Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 7. Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 8. Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 9. Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 10. Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 11. Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 12. North America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 13. North America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 14. North America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 15. North America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 16. North America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 17. North America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 18. North America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 19. North America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 20. North America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 21. North America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 22. United States: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 23. United States: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 24. United States: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 25. United States: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 26. United States: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 27. United States: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 28. United States: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 29. United States: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 30. Canada: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 31. Canada: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 32. Canada: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 33. Canada: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 34. Canada: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 35. Canada: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 36. Canada: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 37. Canada: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 38. Mexico: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 39. Mexico: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 40. Mexico: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 41. Mexico: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 42. Mexico: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 43. Mexico: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 44. Mexico: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 45. Mexico: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 46. Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 47. Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 48. Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 49. Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 50. Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 51. Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 52. Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 53. Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 54. Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 55. Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 56. Germany: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 57. Germany: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 58. Germany: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 59. Germany: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 60. Germany: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 61. Germany: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 62. Germany: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 63. Germany: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 64. United Kingdom: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 65. United Kingdom: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 66. United Kingdom: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 67. United Kingdom: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 68. United Kingdom: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 69. United Kingdom: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 70. United Kingdom: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 71. United Kingdom: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 72. France: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 73. France: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 74. France: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 75. France: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 76. France: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 77. France: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 78. France: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 79. France: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 80. Italy: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 81. Italy: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 82. Italy: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 83. Italy: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 84. Italy: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 85. Italy: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 86. Italy: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 87. Italy: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 88. Russia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 89. Russia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 90. Russia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 91. Russia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 92. Russia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 93. Russia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 94. Russia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 95. Russia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 96. Rest of Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 97. Rest of Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 98. Rest of Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 99. Rest of Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 100. Rest of Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 101. Rest of Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 102. Rest of Europe: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 103. Rest of Europe: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 104. Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 105. Asia Pacific: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 106. Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 107. Asia Pacific: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 108. Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 109. Asia Pacific: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 110. Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 111. Asia Pacific: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 112. Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 113. Asia Pacific: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 114. China: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 115. China: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 116. China: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 117. China: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 118. China: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 119. China: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 120. China: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 121. China: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 122. Japan: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 123. Japan: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 124. Japan: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 125. Japan: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 126. Japan: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 127. Japan: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 128. Japan: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 129. Japan: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 130. India: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 131. India: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 132. India: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 133. India: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 134. India: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 135. India: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 136. India: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 137. India: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 138. Australia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 139. Australia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 140. Australia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 141. Australia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 142. Australia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 143. Australia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 144. Australia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 145. Australia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 146. South Korea: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 147. South Korea: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 148. South Korea: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 149. South Korea: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 150. South Korea: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 151. South Korea: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 152. South Korea: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 153. South Korea: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 154. Rest of APAC: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 155. Rest of APAC: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 156. Rest of APAC: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 157. Rest of APAC: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 158. Rest of APAC: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 159. Rest of APAC: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 160. Rest of APAC: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 161. Rest of APAC: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 162. Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 163. Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 164. Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 165. Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 166. Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 167. Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 168. Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 169. Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 170. Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 171. Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 172. Saudi Arabia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 173. Saudi Arabia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 174. Saudi Arabia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 175. Saudi Arabia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 176. Saudi Arabia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 177. Saudi Arabia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 178. Saudi Arabia: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 179. Saudi Arabia: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 180. South Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 181. South Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 182. South Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 183. South Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 184. South Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 185. South Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 186. South Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 187. South Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 188. United Arab Emirates: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 189. United Arab Emirates: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 190. United Arab Emirates: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 191. United Arab Emirates: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 192. United Arab Emirates: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 193. United Arab Emirates: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 194. United Arab Emirates: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 195. United Arab Emirates: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 196. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 197. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 198. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 199. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 200. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 201. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 202. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 203. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 204. South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 205. South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 206. South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 207. South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 208. South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 209. South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 210. South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 211. South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 212. South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 213. South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 214. Brazil: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 215. Brazil: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 216. Brazil: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 217. Brazil: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 218. Brazil: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 219. Brazil: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 220. Brazil: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 221. Brazil: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 222. Argentina: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 223. Argentina: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 224. Argentina: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 225. Argentina: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 226. Argentina: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 227. Argentina: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 228. Argentina: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 229. Argentina: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 230. Rest of South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Workflow
Table 231. Rest of South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Workflow
Table 232. Rest of South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Service
Table 233. Rest of South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Service
Table 234. Rest of South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by Solutions
Table 235. Rest of South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Solutions
Table 236. Rest of South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 237. Rest of South and Central America: Drug Discovery Informatics Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 238. Heat Map Analysis by Key Players
List of Figures
Figure 1. Drug Discovery Informatics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Ecosystem Analysis
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Drug Discovery Informatics Market Revenue (US$ Million), 2021–2031
Figure 6. Drug Discovery Informatics Market Share (%) – by Workflow (2024 and 2031)
Figure 7. Discovery Informatics: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Drug Development: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Drug Discovery Informatics Market Share (%) – by Service (2024 and 2031)
Figure 10. Sequence Analysis Platform: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Molecular Modelling: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Clinical Trial Data Management: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Docking: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Drug Discovery Informatics Market Share (%) – by Solutions (2024 and 2031)
Figure 16. Software: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Services: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Drug Discovery Informatics Market Share (%) – by End User (2024 and 2031)
Figure 19. Pharmaceutical and Biotechnology Companies: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Contract Research Organizations (CROs): Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Others: Drug Discovery Informatics Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Drug Discovery Informatics Market Breakdown by Region, 2024 and 2031 (%)
Figure 23. North America: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
Figure 24. North America: Drug Discovery Informatics Market Breakdown, by Workflow (2024 and 2031)
Figure 25. North America: Drug Discovery Informatics Market Breakdown, by Service (2024 and 2031)
Figure 26. North America: Drug Discovery Informatics Market Breakdown, by Solutions (2024 and 2031)
Figure 27. North America: Drug Discovery Informatics Market Breakdown, by End User (2024 and 2031)
Figure 28. North America: Drug Discovery Informatics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 29. United States: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 30. Canada: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 31. Mexico: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. Europe: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
Figure 33. Europe: Drug Discovery Informatics Market Breakdown, by Workflow (2024 and 2031)
Figure 34. Europe: Drug Discovery Informatics Market Breakdown, by Service (2024 and 2031)
Figure 35. Europe: Drug Discovery Informatics Market Breakdown, by Solutions (2024 and 2031)
Figure 36. Europe: Drug Discovery Informatics Market Breakdown, by End User (2024 and 2031)
Figure 37. Europe: Drug Discovery Informatics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 38. Germany: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 39. United Kingdom: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 40. France: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 41. Italy: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 42. Russia: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 43. Rest of Europe: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 44. Asia Pacific: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
Figure 45. Asia Pacific: Drug Discovery Informatics Market Breakdown, by Workflow (2024 and 2031)
Figure 46. Asia Pacific: Drug Discovery Informatics Market Breakdown, by Service (2024 and 2031)
Figure 47. Asia Pacific: Drug Discovery Informatics Market Breakdown, by Solutions (2024 and 2031)
Figure 48. Asia Pacific: Drug Discovery Informatics Market Breakdown, by End User (2024 and 2031)
Figure 49. Asia Pacific: Drug Discovery Informatics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 50. China: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 51. Japan: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 52. India: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 53. Australia: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 54. South Korea: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 55. Rest of APAC: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 56. Middle East and Africa: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
Figure 57. Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow (2024 and 2031)
Figure 58. Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service (2024 and 2031)
Figure 59. Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions (2024 and 2031)
Figure 60. Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User (2024 and 2031)
Figure 61. Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 62. Saudi Arabia: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 63. South Africa: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 64. United Arab Emirates: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 65. Rest of Middle East and Africa: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 66. South and Central America: Drug Discovery Informatics Market – Revenue, 2021–2031 (US$ Million)
Figure 67. South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow (2024 and 2031)
Figure 68. South and Central America: Drug Discovery Informatics Market Breakdown, by Service (2024 and 2031)
Figure 69. South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions (2024 and 2031)
Figure 70. South and Central America: Drug Discovery Informatics Market Breakdown, by End User (2024 and 2031)
Figure 71. South and Central America: Drug Discovery Informatics Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 72. Brazil: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 73. Argentina: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 74. Rest of South and Central America: Drug Discovery Informatics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 75. Company Market Share Analysis, 2024
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For